NASDAQ:SNPS Synopsys (SNPS) Stock Price, News & Analysis $451.19 +3.57 (+0.80%) Closing price 10/21/2026 04:00 PM EasternExtended Trading$445.50 -5.69 (-1.26%) As of 07:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Synopsys Stock (NASDAQ:SNPS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Synopsys alerts:Sign Up Key Stats Today's Range$450.01▼$459.8850-Day Range$367.70▼$509.9952-Week Range$362.55▼$539.48Volume1.34 million shsAverage Volume2.66 million shsMarket Capitalization$86.46 billionP/E Ratio79.72Dividend YieldN/APrice Target$575.00Consensus RatingModerate Buy Company Overview Synopsys, Inc. is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems. The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs. In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle. The company serves customers worldwide, including semiconductor manufacturers, systems companies, electronics manufacturers and software developers. Synopsys was founded in 1986 and is headquartered in Sunnyvale, California. Sassine Ghazi serves as president and chief executive officer, while company founder Aart de Geus serves as executive chairman.AI Generated. May Contain Errors. Read More Synopsys Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks94th Percentile Overall ScoreSNPS MarketRank™: 4.71577261809 of 5 starsSynopsys scored higher than 94% of companies evaluated by MarketBeat, and ranked 46th out of 591 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingSynopsys has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 1 strong buy rating, 22 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialSynopsys has a consensus price target of $575.00, representing about 27.4% upside from its current price of $451.19.Amount of Analyst CoverageSynopsys has been the subject of 17 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Synopsys' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth26.36% Earnings GrowthEarnings for Synopsys are expected to grow by 26.36% in the coming year, from $11.00 to $13.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Synopsys is 79.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 36.57.Price to Earnings Ratio vs. SectorThe P/E ratio of Synopsys is 79.72, which means that it is trading at a more expensive P/E ratio than the Technology sector average P/E ratio of about 70.13.Price to Earnings Growth RatioSynopsys has a PEG Ratio of 1.82. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSynopsys has a P/B Ratio of 2.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Synopsys' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.61% of the float of Synopsys has been sold short.Short Interest Ratio / Days to CoverSynopsys has a short interest ratio ("days to cover") of 2.41, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Synopsys has recently decreased by 12.94%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSynopsys does not currently pay a dividend.Dividend GrowthSynopsys does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.98 News SentimentSynopsys has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 29 news articles for Synopsys this week, compared to 8 articles on an average week.Search InterestOnly 39 people have searched for SNPS on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows25 people have added Synopsys to their MarketBeat watchlist in the last 30 days. This is an increase of 213% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Synopsys insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $51,366,457.00 in company stock.Percentage Held by Insiders0.56% of the stock of Synopsys is held by insiders.Percentage Held by Institutions85.47% of the stock of Synopsys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Synopsys' insider trading history. Receive SNPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Synopsys and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNPS Stock News HeadlinesSynopsys (NASDAQ:SNPS) Stock Gets Price Target Increase from Morgan StanleyOctober 22 at 2:03 AM | americanbankingnews.comSynopsys Undervalued as Market Overlooks AI Revenue Opportunity, Morgan Stanley SaysOctober 20 at 1:56 PM | finance.yahoo.com“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 22 at 1:00 AM | Weiss Ratings (Ad)Synopsys, Inc. (NASDAQ:SNPS) Stock Has Average Target Price of $571.78October 20 at 4:15 AM | americanbankingnews.comSynopsys (NASDAQ:SNPS) CEO Sells $6,759,315.36 in StockOctober 17, 2026 | insidertrades.comMarketBeat Week in Review – 10/12 - 10/16 (SNPS)Tech stocks fell on inflation fears and AI infrastructure concerns while the Dow rose, as MarketBeat analysts review earnings outlooks, sector rotation, and stock picks from the week's top stories.October 17, 2026 | marketbeat.comSynopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise TargetsSynopsys launched a $1 billion accelerated share repurchase after its Investor Day, as raised guidance and Amazon and OpenAI deals drove analysts to lift price targets.October 15, 2026 | marketbeat.comIs Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAISynopsys has rallied after a $1 billion Amazon IP deal and an OpenAI chip-design partnership, prompting the company to raise its long-term revenue and margin guidance through fiscal 2030.October 10, 2026 | marketbeat.comSee More Headlines SNPS Stock Analysis - Frequently Asked Questions How have SNPS shares performed this year? Synopsys' stock was trading at $469.72 on January 1st, 2026. Since then, SNPS shares have decreased by 3.9% and is now trading at $451.19. How were Synopsys' earnings last quarter? Synopsys, Inc. (NASDAQ:SNPS) issued its quarterly earnings data on Wednesday, August, 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.67 by $0.24. The firm's quarterly revenue was up 42.4% on a year-over-year basis. Read the conference call transcript. Is Synopsys buying back stock? Synopsys' Board of Directors initiated a stock buyback plan on Monday, October 5th 2026, which authorizes the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 1.1% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's leadership believes its shares are undervalued. Does Synopsys have any subsidiaries? The following companies are subsidiaries of Synopsys: Moortec Semiconductor, Terrain EDA, Tinfoil Security, QTronic GmbH, PhoeniX Software, Kilopass Technology, Black Duck Software, and others. Who are Synopsys' major shareholders? Top institutional shareholders of Synopsys include Assenagon Asset Management S.A. (1.42%), Sustainable Growth Advisers LP (0.41%), Vontobel Holding Ltd. (0.21%) and Robeco Institutional Asset Management B.V. (0.14%). Insiders that own company stock include Geus Aart De, Sassine Ghazi, Sudhindra Kankanwadi, Roy Vallee, John F Runkel Jr, Janet Lee, Shelagh Glaser, Marc N Casper, Mercedes Johnson and Richard S Mahoney. View institutional ownership trends. How do I buy shares of Synopsys? Shares of SNPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Synopsys own? Based on aggregate information from My MarketBeat watchlists, some other companies that Synopsys investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Broadcom (AVGO), Salesforce (CRM) and Taiwan Semiconductor Manufacturing (TSM). Company Calendar Last Earnings8/26/2026Today10/22/2026Fiscal Year End10/31/2026Next Earnings (Estimated)12/09/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, SNPS's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolNASDAQ:SNPS CIK883241 Webwww.synopsys.com Phone(650) 584-5000Fax650-965-8637Employees28,000Year Founded1986Price Target and Rating Average Price Target for Synopsys$575.00 High Price Target$640.00 Low Price Target$475.00 Potential Upside/Downside+27.4%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage26 Analysts Profitability EPS (Trailing Twelve Months)$5.66 Trailing P/E Ratio79.72 Forward P/E Ratio41.02 P/E Growth1.82Net Income$1.33 billion Net Margins11.43% Pretax Margin13.79% Return on Equity6.24% Return on Assets3.95% Debt Debt-to-Equity Ratio0.29 Current Ratio1.34 Quick Ratio1.24 Sales & Book Value Annual Sales$9.42 billion Price / Sales9.18 Cash Flow$11.95 per share Price / Cash Flow37.76 Book Value$152.50 per share Price / Book2.96Miscellaneous Outstanding Shares191,637,000Free Float190,564,000Market Cap$86.46 billion OptionableOptionable Beta1.21 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SNPS) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synopsys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synopsys With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.